Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)Cognition Disorders, Cognitive Dysfunction, Hemic and Lymphatic Diseases, Mild Cognitive Impairment, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, cognitive disorder, dementia, diabetes mellitus, endocrine system disorder, follicular lymphoma, glucose metabolism disease, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, metabolic disease, neoplasm, nervous system disorder, psychiatric disorder, type 2 diabetes mellitusRecruitingPhase 32026-09-02NCT07083154

8 results · Page 1 of 1

8 results · Page 1 of 1

Swipe the table sideways for more columns.